Custom Antibody Market :
Custom antibody market was valued at USD 40.97 Billion in 2021, registering a CAGR of 27.2% during the forecast period (2022-2030), and is projected to be worth USD 146.40 Billion by 2030. The host proteins that the human body produces as a response to the ingestion of foreign substances or compounds are known as antibodies. The natural ability of the human body to produce unique antibodies in response to antigens that stand for certain infections or medical disorders is being used by researchers from all over the world in a variety of research projects.
Custom Antibody Market Dynamics:
The process of customizing antibodies for use in research and development is known as custom antibody services. In recent years, there has been a noticeable rise in the demand for the newest diagnostic medical methods. This expansion can be attributed to rising prevalence rates, a general audience that has approved tailored items with high-quality standards, rising healthcare spending, and increased awareness for public health issues among technology advancements.
Driver:
An increase in hospitals, increased government spending on healthcare, and greater disease awareness are the main market-driving factors. Over the projected period, the need for custom antibody services will also increase as personalized cancer care becomes more prevalent.
Restraint:
The presence of alternative antibodies in the custom antibody market is expected to hamper the growth of the market during the forecast period.
Opportunities:
A key area of research in the healthcare sector, personalized medicine has now permeated mainstream clinical practice and is revolutionizing how many diseases are diagnosed, categorized, and treated. These developments are especially noticeable in oncology. Hence, increasing demand for personalized medicines in protein therapeutics is anticipated to boost the growth of the custom antibody market.
COVID-19 Analysis of Custom Antibody Market:
The custom antibody market has been severely impacted since the COVID-19 epidemic in many different parts of the world. Shipments were impacted during the initial lockdown due to a labor shortage and the closure of a manufacturing facility. The pandemic’s initial effects on China were tremendous. However, the nation’s circumstances have stabilized, and all product and service production rates have increased. As a result, it is determined that COVID-19’s overall impact on the custom antibody market is moderate.
Custom Antibody Market Report Cover:
| Report Attributes | Report Details |
| Study Timeline | 2016-2030 |
| Market Size in 2030 (USD Billion) | 146.40 Billion |
| CAGR (2022-2030) | 15.2% |
| By Service | Antibody Development, Antibody Production & Purification, Antibody Fragmentation & Labeling |
| By Type | Monoclonal Antibodies, Polyclonal Antibodies
Recombinant Antibodies, Other Custom Antibodies |
| By Source | Mice, Rabbits, Other Sources |
| By Research Area | Oncology, Infectious Diseases, Neurobiology
Stem Cells, Immunology, Cardiovascular Disease, Other Research Areas |
| By End -Use | Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations |
| By geography | North America– (U.S., Canada, Mexico)
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe) Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific) Latin America- (Brazil, Argentina, Chile, Rest of Latin America) The Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA) |
| Key Players | Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc, Merck Group, Cell Signaling Technology, Inc., GenScrip, BioLegend, Rockland Immunochemicals, Agilent Technologies, Inc., BioLegend, Inc., Innovagen AB |
Custom Antibody Market Segment Analysis:
By Service
The service segment of the custom antibody market is divided into categories such as antibody production & purification, antibody development, and antibody fragmentation & labeling. The custom antibody market’s antibody development segment held the biggest market share in 2021. This market’s substantial position can be attributable to researchers’ increased emphasis on high-quality custom antibodies for reproducibility, which is limited by the use of commercially available antibodies. Hence, these factors are expected to boom the growth of the custom antibody market during the forecast period.
By Type
Monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and other custom antibodies are the types of antibodies in the custom antibody market. In 2021, the monoclonal antibodies market category held the greatest market share. This is since monoclonal antibodies are the preferred option in all types of research studies due to their high specificity and selectivity compared to other antibodies. Further, increasing demand for monoclonal antibodies in research studies is anticipated to fuel the growth of the custom antibody market.
By Source
Based on the source the custom antibody market has been divided into mice, rabbits, and other sources. The custom antibody market for mice held the greatest market share in 2021. As mice are preferred hosts for research and development activity-use antibody production due to their anatomical, physiological, and genetic similarity to humans. Moreover, mice have an advantage over other experimental animals and their tiny size makes them easier to maintain and handle.
By Research Area
The custom antibody market is divided into oncology, infectious diseases, neuroscience, stem cells, immunology, cardiovascular disease, and other research areas depending on the field of study. In 2021, the oncology sector held the biggest market share for customized antibodies. The prevalence of therapeutic mAbs in cancer research and clinical trials has increased as a result of cancer is one of the top causes of death in the world. This is a significant component contributing to the oncology segment’s significant market share.
By End-Use
The custom antibody market based on end-use is divided into pharmaceutical and biotechnology firms, academic and research institutions, and contract research firms. In 2021, the segment of pharmaceutical and biotechnology firms held the biggest market share for custom antibodies. The expansion of proteomics and genomics research, the need for antibodies in the identification of new targets and assays, and the expansion of R&D activities in various therapeutic areas such as cancer, immunodeficiency diseases, HIV, and blood disorders are the main factors influencing the demand for custom antibodies by pharmaceutical and biotechnology companies.
By Region
Latin America, the Middle East & Africa, North America, Europe, the Asia Pacific, and the custom antibody market are the major sub-regions. The custom antibody market’s greatest market shares in 2021 belonged to North America. This region’s significant market share can be attributed to rising investments in the creation of structure-based drug designs, expanding genomics and proteomics research, rising needs for high-quality research tools to ensure data reproducibility, and growing attention to creating antibody-based therapeutics. Another important aspect of the substantial share of this market segment is the existence of numerous international competitors in this area.
Custom Antibody Market Competitive Landscape:
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. The majority of manufacturers are concentrating on new Service launches, improvements to current Services, and mergers and acquisitions. –
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc
- Merck Group
- Cell Signaling Technology, Inc.
- GenScript
- BioLegend
- Rockland Immunochemicals
- Agilent Technologies, Inc.
- BioLegend, Inc.
- Innovagen AB
Recent Development
- SunRock Biopharma and GenScript collaborated to create potential therapeutic antibody candidates in 2021. SunRock Biopharma will get help from GenScript with developing cell lines, manufacturing therapeutic products, developing processes for GMP pharmacological substances, and finding antibodies.
- To expand Abcam’s clientele, Abcam plc and Abingdon Health (UK) signed a partnership and co-marketing agreement in 2021.
Table of Content
- Introduction
- Market Introduction
- Market Research Methodology
- Research Process
- Primary Research
- Secondary Research
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Limitations of the Study
- Product Picture of Custom Antibody
- Global Custom Antibody Market: Classification
- Geographic Scope
- Years Considered for the Study
- Research Methodology in brief
- Parent Market Overview
- Overall Custom Antibody Market Regional Demand
- Research Programs/Design
- Market Breakdown and Data Triangulation Approach
- Data Source
- Secondary Sources
- Primary Sources
- Primary Interviews
- Average Type primary breakdown ratio
- Market Dynamics
- Drivers
- Drivers
- Restraints
- Restraints
- Opportunity
- Impact forces on market dynamics
- Impact forces during the forecast years
- Industry Value Chain
- Upstream analysis
- Downstream analysis
- Therapeutic
- Direct Channel
- Indirect Channel
- Potential Customers
- Manufacturing/Operational Cost Analysis
- Pricing Analysis by Region
- Key Service Landscape
- Regulatory Analysis
- Porter’s Analysis
- Supplier Power
- Buyer Power
- Substitution Threat
- Threat from New Entry
- Competitive Rivalry
- PESTEL Analysis
- Political Factors
- Economic Factor
- Social Factors
- Technological Factor
- Environmental Factors
- Legal Factor
- Covid-19 impact on Global Economy
- Covid-19 impact on Custom Antibody Market demand
- Post-Covid Impact on Custom Antibody Market Demand
- Impact Analysis of Russia-Ukraine Conflict
- Drivers
- Global Custom Antibody Market Segmentation, Revenue (USD Billion), (2022-2030)
- By Service
- Antibody Development
- Antibody Production & Purification
- Antibody Fragmentation & Labeling
- By Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- Other Custom Antibodies
- By Source
- Mice
- Rabbits
- Other Sources
- By Research Area
- Oncology
- Infectious Diseases
- Neurobiology
- Stem Cells
- Immunology
- Cardiovascular Disease
- Other Research Areas
- End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations
- By Service
- By Global Custom Antibody Market Overview, By Region
- North America Custom Antibody Market Revenue (USD Billion), by Countries, (2022-2030)
- US
- By Service
- By Type
- By Source
- By Research Area
- By End-use
- Canada
- Mexico
- US
- Europe Custom Antibody Market Revenue (USD Billion), by Countries, (2022-2030)
- France
- UK
- Spain
- Russia
- Italy
- BENELUX
- Asia Pacific Custom Antibody Market Revenue (USD Billion), by Countries, (2022-2030)
- China
- Japan
- Australia
- South Korea
- India
- ASEAN
- North America Custom Antibody Market Revenue (USD Billion), by Countries, (2022-2030)
- Latin America Custom Antibody Market Revenue (USD Billion), by Countries, (2022-2030)
- Brazil
- Argentina
- Chile
- The Middle East and Africa Custom Antibody Market Revenue (USD Billion), by Countries, (2022-2030)
- GCC
- Turkey
- South Africa
- Global Custom Antibody Market Revenue: Competitive Analysis, 2021
- Key strategies by players
- Revenue (USD Billion and %), By manufacturers, 2021
- Player Positioning by Market Players, 2021
- Competitive Analysis
- Thermo Fisher Scientific, Inc.
- Business Overview
- Business Financials (USD Billion)
- Service Category, Source, and Specification
- Main Business/Business Overview
- Geographical Analysis
- Recent Development
- Swot Analysis
- Bio-Rad Laboratories, Inc
- Merck Group
- Cell Signaling Technology, Inc.
- GenScript
- BioLegend
- Rockland Immunochemicals
- Agilent Technologies, Inc.
- BioLegend, Inc.
- Innovagen AB
- Thermo Fisher Scientific, Inc.
- Market Research Findings & Conclusion
Disclaimer
Research Methodology
The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.